Welcome to our dedicated page for Ibex SEC filings (Ticker: IBEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the story behind IBEX’s rapid expansion into AI-powered contact centers? Start with the disclosures investors trust most. Our SEC Filings hub untangles every IBEX document—whether you need the IBEX annual report 10-K simplified to gauge client concentration risk or an IBEX quarterly earnings report 10-Q filing to track segment margins.
Finding those details across hundreds of pages is tedious. Stock Titan applies AI that highlights wage inflation in nearshore sites, flags capital spending on the Wave iX platform, and provides instant alerts for IBEX insider trading Form 4 transactions. The result: understanding IBEX SEC documents with AI becomes a five-minute task.
Use the menu to jump straight to what professionals ask for most:
- Real-time Form 4 feed – follow IBEX executive stock transactions Form 4 and get context around each trade.
- 8-K event briefs – see IBEX 8-K material events explained minutes after they hit EDGAR, from new client wins to leadership changes.
- DEF 14A proxy tools – decode IBEX proxy statement executive compensation without spreadsheet gymnastics.
- Earnings pack – one click reveals our IBEX earnings report filing analysis and historical KPIs.
Every filing—10-K, 10-Q, 8-K, S-8, SC 13G, or the next IBEX Form 4 insider transactions real-time—arrives here within seconds of EDGAR publication and is paired with plain-English summaries. Monitor contract renewal clauses, compare headcount by region, or assess AI capital spend—all without sifting through dense legal text. Complex disclosures, made clear.
IBEX Ltd (IBEX) Form 4 filing discloses two open-market sales by Chief Executive Officer and Director Robert Thomas Dechant on 2 and 3 July 2025. The transactions involved a total of 5,000 common shares sold at $30.00 per share, producing proceeds of roughly $150,000. Following the dispositions, Dechant’s direct ownership declined from 198,633 to 193,633 shares, a reduction of about 2.5% of his previously held stake. No derivative security activity was reported, and the filing was submitted individually on 3 July 2025.
The modest size of the sale relative to Dechant’s remaining holdings suggests routine portfolio management rather than a wholesale change in insider sentiment. Nonetheless, any CEO sale can attract investor attention, particularly when not explicitly tied to a pre-arranged 10b5-1 trading plan (the form does not indicate such a plan was in place).